TANDEM DIABETES CARE, INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
Control-IQ Technology in Individuals With Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Treated With Insulin
- Interventions
- Device: Control-IQ technology 1.5
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05111301
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
๐บ๐ธIcahn School of Medicine at Mt. Sinai, New York, New York, United States
๐บ๐ธTexas Diabetes and Endocrinology, Austin, Texas, United States
Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Device: Control-IQ technology 2.0
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT05014789
- Locations
- ๐บ๐ธ
University of Virginia, Charlottesville, Virginia, United States
Control-IQ Observational (CLIO) Post-Approval Study
Completed
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 3157
- Registration Number
- NCT04503174
- Locations
- ๐บ๐ธ
Tandem Diabetes, San Diego, California, United States
Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Device: Predictive Low Glucose Suspend
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT03195140
- Locations
- ๐บ๐ธ
William Sansum Diabetes Center, Santa Barbara, California, United States
๐บ๐ธBarbara Davis Center, Aurora, Colorado, United States
๐บ๐ธStanford University, Palo Alto, California, United States
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
Phase 1
Completed
- Conditions
- Insulin PumpType 1 DiabetesDiabetes Mellitus
- First Posted Date
- 2016-08-24
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02877771
- Locations
- ๐บ๐ธ
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
๐บ๐ธStanford University, Palo Alto, California, United States
Validation Study of G4 User Interface
Completed
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT01142895
ยฉ Copyright 2025. All Rights Reserved by MedPath